Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001582 |
---|---|
Receipt number | R000001768 |
Scientific Title | Feasibility study of TC(docetaxel+Cyclophosphamide)as adjuvant chemotherapy for intermediate risk primary breast cancer with HER2-negative and ER-positive tumor(KBC-SG 0803) |
Date of disclosure of the study information | 2008/12/17 |
Last modified on | 2010/08/04 15:19:45 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/12/17 08:33:58 | ||
2 | Update | 2008/12/19 16:10:00 | Public title Acronym |
|
3 | Update | 2008/12/19 16:38:54 | Narrative objectives1 Narrative objectives1 Key secondary outcomes |
|
4 | Update | 2008/12/19 17:17:57 | Key inclusion criteria Key exclusion criteria |
|
5 | Update | 2010/06/17 09:48:05 | Recruitment status |
|
6 | Update | 2010/08/04 15:19:45 | Recruitment status |